Naoko Ronquest

533 total citations
21 papers, 399 citations indexed

About

Naoko Ronquest is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Naoko Ronquest has authored 21 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 7 papers in Epidemiology and 6 papers in Economics and Econometrics. Recurrent topics in Naoko Ronquest's work include Opioid Use Disorder Treatment (10 papers), Substance Abuse Treatment and Outcomes (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Naoko Ronquest is often cited by papers focused on Opioid Use Disorder Treatment (10 papers), Substance Abuse Treatment and Outcomes (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Naoko Ronquest collaborates with scholars based in United States, United Kingdom and Malaysia. Naoko Ronquest's co-authors include Vijay R. Nadipelli, Bernd Wollschlaeger, Tina M. Willson, Leslie Montejano, Walter Ling, Susan M. Learned, Christian Heidbreder, Vishaal Mehra, Caitlyn T. Solem and Yu‐Chen Yeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Health and Quality of Life Outcomes and Clinical Therapeutics.

In The Last Decade

Naoko Ronquest

20 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoko Ronquest United States 11 287 191 76 62 44 21 399
Richard Littlewood United Kingdom 12 249 0.9× 238 1.2× 62 0.8× 39 0.6× 35 0.8× 24 418
William J. Parish United States 11 216 0.8× 125 0.7× 83 1.1× 61 1.0× 44 1.0× 24 388
Jeffrey D. Baxter United States 10 290 1.0× 222 1.2× 19 0.3× 118 1.9× 14 0.3× 13 398
Taylor A. Ochalek United States 7 174 0.6× 96 0.5× 38 0.5× 37 0.6× 25 0.6× 15 256
Martha J. Wunsch United States 8 277 1.0× 127 0.7× 103 1.4× 93 1.5× 52 1.2× 16 361
Emlyn S. Jones United States 6 236 0.8× 137 0.7× 63 0.8× 46 0.7× 47 1.1× 8 388
Randall Hoskinson United States 8 428 1.5× 387 2.0× 30 0.4× 186 3.0× 47 1.1× 15 611
Sarah Gutkind United States 10 150 0.5× 201 1.1× 18 0.2× 65 1.0× 79 1.8× 29 378
Ryan McDonald United States 12 505 1.8× 437 2.3× 35 0.5× 230 3.7× 64 1.5× 25 614
James Fetherston Australia 9 170 0.6× 271 1.4× 28 0.4× 46 0.7× 89 2.0× 13 424

Countries citing papers authored by Naoko Ronquest

Since Specialization
Citations

This map shows the geographic impact of Naoko Ronquest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Ronquest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Ronquest more than expected).

Fields of papers citing papers by Naoko Ronquest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Ronquest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Ronquest. The network helps show where Naoko Ronquest may publish in the future.

Co-authorship network of co-authors of Naoko Ronquest

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Ronquest. A scholar is included among the top collaborators of Naoko Ronquest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Ronquest. Naoko Ronquest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koenig, Aaron, et al.. (2024). Health state utility estimates for value assessments of novel treatments in Huntington’s disease: a systematic literature review. Health and Quality of Life Outcomes. 22(1). 33–33. 1 indexed citations
2.
Drummond, Michael, Federico Augustovski, Yingyao Chen, et al.. (2022). Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report. Value in Health. 25(8). 1257–1267. 14 indexed citations
3.
Ronquest, Naoko, et al.. (2022). Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations. ClinicoEconomics and Outcomes Research. Volume 14. 499–511. 3 indexed citations
4.
5.
Ling, Walter, Vijay R. Nadipelli, Arnie Aldridge, et al.. (2020). Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study. Journal of Addiction Medicine. 14(5). e233–e240. 39 indexed citations
6.
Ling, Walter, Vijay R. Nadipelli, Caitlyn T. Solem, et al.. (2019). <p>Measuring recovery in opioid use disorder: clinical utility and psychometric properties of the Treatment Effectiveness Assessment</p>. PubMed. Volume 10. 13–21. 15 indexed citations
7.
Ling, Walter, Vijay R. Nadipelli, Caitlyn T. Solem, et al.. (2019). Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: A long-term study. Journal of Substance Abuse Treatment. 110. 1–8. 45 indexed citations
8.
Ling, Walter, Vijay R. Nadipelli, Caitlyn T. Solem, et al.. (2019). Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study. Journal of Addiction Medicine. 13(6). 442–449. 37 indexed citations
9.
Ronquest, Naoko, Tina M. Willson, Leslie Montejano, Vijay R. Nadipelli, & Bernd Wollschlaeger. (2018). Relationship between buprenorphine adherence and relapse, health care utilization and costs in privately and publicly insured patients with opioid use disorder. PubMed. Volume 9. 59–78. 74 indexed citations
10.
Ling, Walter, Vijay R. Nadipelli, Naoko Ronquest, et al.. (2018). Remission from chronic opioid use—Studying environmental and socio-economic factors on recovery (RECOVER): Study design and participant characteristics. Contemporary Clinical Trials. 76. 93–103. 15 indexed citations
11.
Ruetsch, Charles, et al.. (2017). Heterogeneity of nonadherent buprenorphine patients: subgroup characteristics and outcomes.. PubMed. 23(6). e172–e179. 22 indexed citations
12.
Mladsi, Deirdre, et al.. (2017). An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia. Hospital Practice. 45(3). 111–117. 4 indexed citations
13.
Wollschlaeger, Bernd, Tina M. Willson, Leslie Montejano, Naoko Ronquest, & Vijay R. Nadipelli. (2017). Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse. Journal of Opioid Management. 13(4). 207–220. 21 indexed citations
14.
Tkacz, Joseph, et al.. (2016). Relapse In Opioid Use Disorder: Implications For Health Care Utilization And Costs. Value in Health. 19(3). A188–A188. 1 indexed citations
15.
Tkacz, Joseph, et al.. (2016). The Association Between Buprenorphine Medication-Assisted Treatment Adherence And Health Care Service Utilization And Costs. Value in Health. 19(3). A187–A187. 3 indexed citations
16.
Mladsi, Deirdre, et al.. (2016). Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac. Clinical Therapeutics. 38(11). 2418–2429.
17.
Boscarino, Joseph A., H. Lester Kirchner, Vijay R. Nadipelli, et al.. (2016). Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system. SHILAP Revista de lepidopterología. Volume 7. 131–141. 56 indexed citations
18.
Odom, Dawn, Deirdre Mladsi, Kenneth G. Saag, et al.. (2014). Relationship Between Diclofenac Dose and Risk of Gastrointestinal and Cardiovascular Events: Meta-Regression Based on Two Systematic Literature Reviews. Clinical Therapeutics. 36(6). 906–917. 27 indexed citations
19.
Ronquest, Naoko, et al.. (2011). Measuring the biases in self-reported disability status: evidence from aggregate data. Applied Economics Letters. 18(11). 1053–1060. 10 indexed citations
20.
Mladsi, Deirdre, et al.. (2010). PMC19 THE THRESHOLD PRICING MODEL: NOT JUST ANOTHER COSTEFFECTIVENESS MODEL. Value in Health. 13(7). A332–A332. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Littlewood Breakdown of academic impact, for papers by William J. Parish Breakdown of academic impact, for papers by Jeffrey D. Baxter Breakdown of academic impact, for papers by Taylor A. Ochalek Breakdown of academic impact, for papers by Martha J. Wunsch Breakdown of academic impact, for papers by Emlyn S. Jones Breakdown of academic impact, for papers by Randall Hoskinson Breakdown of academic impact, for papers by Sarah Gutkind Breakdown of academic impact, for papers by Ryan McDonald Breakdown of academic impact, for papers by James Fetherston
Rankless by CCL
2026